pharma
AZ and MSD’s Lynparza becomes first PARP inhibitor approved in US for metastatic breast cancer
January 15, 2018Sales and Marketing AstraZeneca, Cancer, FDA, MSD, breast cancer, lynparza, pharma
The FDA has announced that it has awarded marketing authorisation in the US to Lynparza (olaparib), a poly ADP-ribose polymerase …
Universal flu vaccine receives Google’s financial backing
January 15, 2018Sales and Marketing Vaccine, biotech, drugs, flu, pharma, pharmaceutical
Vaccitech, a spin-out company from the University of Oxford, recently launched a Series A financing round and had some fairly …
FDA steps in to prohibit codeine cough syrups for children
January 12, 2018Medical Communications FDA, biotech, drugs, pharma, pharmaceutical
The FDA has announced that it will require all labels to state that cough syrups containing codeine or hydrocodone are …
Roche’s Ocrevus gets the go ahead in Europe for two forms of MS
January 12, 2018Medical Communications, Sales and Marketing Europe, European Commission, Ocrevus, Roche, multiple sclerosis, pharma
Roche has revealed that its multiple sclerosis (MS) drug Ocrevus (ocrelizumab) has been awarded marketing approval in Europe by the …
Another Alzheimer’s drug bites the dust in P3
January 12, 2018Medical Communications, Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical
It’s been a terrible week for Alzheimer’s disease research, after Pfizer shuttered its neuroscience unit and
Novartis prises Pfizer’s Oncology Head away
January 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Pfizer, biotech, drugs, pharma, pharmaceutical
Novartis has been looking to find someone to fill the shoes of Bruno Strigini since it was revealed that he …
Teva execs feel the pinch, after pay halved
January 11, 2018Medical Communications, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical
Teva’s current crisis is built upon problems that run deep into the company, after numerous acquisitions left it bloated and …
AZ’s Fasenra approved in Europe as an add-on for severe eosinophilic asthma
January 11, 2018Research and Development AstraZeneca, European Commission, Fasenra, MedImmune, asthma, pharma
AstraZeneca and its biologics R&D unit MedImmune have announced that their drug Fasenra (benralizumab) has received approval from the European …
AIDS charity lambasts “ethically challenged” Gilead over price hikes
January 11, 2018Sales and Marketing AIDS, Gilead, HIV, Truvada, biotech, drugs, pharma, pharmaceutical
The AIDS Healthcare Foundation (AHF) has strongly criticised Gilead prices increases across the board for its HIV and AIDS treatment, …
Nestle reportedly pulls out in front to buy Merck KGaA consumer health unit with $5 billion bid
January 11, 2018Sales and Marketing Merck KGaA, nestle, pharma
It has been reported that Swiss food giant Nestle has pulled out in front as the top bidder for Merck …
NHS no longer able to deliver on standards, warn bosses
January 11, 2018Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
The struggles of the NHS this winter are no secret, especially after being front and centre of the first Prime …
Dr Aidan Murphy becomes Ipsen’s new Executive VP, Technical Operations
January 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma
Dr Aidan Murphy has been named by Ipsen’s new Executive Vice President, Technical Operations, succeeding Jonathan Barnsley who retired at …
New project examining FDA-approved drugs for Alzheimer’s, worries over research remains
January 10, 2018Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical
It’s been a gloomy period for research into Alzheimer’s disease treatments in the last week, Pfizer announced it would be …
Bayer and J&J successfully reverse $28 million Xarelto court payout
January 10, 2018Research and Development, Sales and Marketing Bayer, J&J, JJ, Johnson & Johnson, Xarelto, pharma
Bayer and Johnson & Johnson have managed to avert a payout of $27.8 million after a Pennsylvania state court judge …
Slow-release, once-weekly pill for HIV developed
January 10, 2018Research and Development HIV, Lyndra, biotech, drugs, pharma, pharmaceutical
Patient adherence is a big issue across the healthcare system, where individuals, even with the most serious conditions, do not …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
